Annual reports from the research groups:

Li Y, Li X, Li X, Zhong Y, Ji Y, Yu D, Zhang M, Wen JG, Zhang H, Goscinski MA, Nesland JM, Suo Z (2025)
Retraction: PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence
Oncotarget, 16, 790
DOI 10.18632/oncotarget.28777, PubMed 41201955

Reid S, Sandling JK, Pucholt P, Sayadi A, Frodlund M, Lerang K, Gunnarsson I, Jönsen A, Syvänen AC, Molberg Ø, Rantapää-Dahlqvist S, Rudin A, Sjöwall C, Svenungsson E, Bengtsson AA, Rönnblom L, Leonard D (2025)
Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large-scale analysis of genetic predisposition and disease subtypes
J Intern Med (in press)
DOI 10.1111/joim.70040, PubMed 41200769

Blomberg B, Myklebust NN, Oppegaard O, Tøndel C, Cox RJ, Iversen A, Lehmann ME, Sandvig A, Dahl TB, Valderhaug VD, Szodoray P, Wilhelmsen M, Kirsebom BE, Glambek M, Kaarbøe O, Aukrust P, Lie RT, Langeland N (2025)
Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR Trial
Trials, 26 (1), 477
DOI 10.1186/s13063-025-09226-6, PubMed 41199272

Assis DN, Hov JR (2025)
Phase 2 Clinical Trials in Primary Sclerosing Cholangitis: Making the Most of Every Opportunity?
J Hepatol (in press)
DOI 10.1016/j.jhep.2025.10.022, PubMed 41197906